Lidothol Gel
Product Images NDC 80425-0516

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidothol (NDC 80425-0516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lidothol Gel 99g (Lidothol Gel 80425 0516 01)

Lidothol Gel 99g (Lidothol Gel 80425 0516 01)
This is a description of a package labeled as "LIDOTHOL GEL" with a quantity of 99 grams. The NDC numbers are provided as 80425-0516-01 (source NDC: 83881-0455-35). It indicates the lot number as "XXXXXX" with an expiration date of December 31, 2026. The text also mentions "anoo geL g9" with a barcode serial number of "000000372720". Additional details state "o on teprarat e."*
FDA Label Image

Package Insert (1) (Lidothol Package Insert 102424 01 (1))

Package Insert (1) (Lidothol Package Insert 102424 01 (1))
This text provides detailed information about the dosage, administration, handling, disposal, adverse reactions, and clinical pharmacology of Lidothol™, a gel containing 4.5% Lidocaine HCL and 5% Menthol used for topical pain relief. It includes instructions on application, potential side effects, warnings about absorption when used with other local anesthetic products, safety precautions, overdosage management, and a list of ingredients. The description also outlines the pharmacodynamics and pharmacokinetics of Lidocaine, emphasizing the absorption levels from the gel applied to the skin. Additionally, it mentions the potential systemic side effects and adverse reactions associated with the product, providing a comprehensive overview for healthcare professionals and consumers.*
FDA Label Image

Package Insert (2) (Lidothol Package Insert 102424 02 (1))

Package Insert (2) (Lidothol Package Insert 102424 02 (1))
Lidothol™ is a topical medication indicated for relieving pain associated with various conditions such as arthritis, backache, cramps, and strains when applied to intact skin. It contains lidocaine, which is distributed in the body and primarily bound to plasma proteins. The drug is metabolized in the skin and excreted by the kidneys. However, caution is advised in patients with certain conditions like hepatic disease or sensitivity to local anesthetics. There are warnings regarding the risk of methemoglobinemia, excessive dosing, and precautions related to allergic reactions, application on non-intact skin, use with external heat sources, eye exposure, and potential drug interactions. It is essential to follow instructions carefully to avoid adverse effects and seek medical attention if needed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.